Prescription drug · ANDA
Sodium chloride NDC 17271-701
Sodium chloride 9 mg/mL · Injection, Solution · Intravenous · Becton Dickinson and Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 17271-701-02 | 17271070102 | 50 mL in 1 BAG (17271-701-02)Marketed from Sep 19, 2017 | |
| 17271-701-03 | 17271070103 | 100 mL in 1 BAG (17271-701-03)Marketed from Sep 19, 2017 | |
| 17271-701-05 | 17271070105 | 250 mL in 1 BAG (17271-701-05)Marketed from Sep 19, 2017 | |
| 17271-701-06 | 17271070106 | 500 mL in 1 BAG (17271-701-06)Marketed from Sep 19, 2017 | |
| 17271-701-07 | 17271070107 | 1000 mL in 1 BAG (17271-701-07)Marketed from Sep 19, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium chloride
- Generic name (nonproprietary)
- sodium chloride
- Active ingredients
- Sodium chloride — 9 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Becton Dickinson and Company
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207310
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
- Identifiers
- Product ID 17271-701_31344de2-e115-440a-a913-ff63da5f17d8SPL ID 31344de2-e115-440a-a913-ff63da5f17d8SPL set ID ebc8b008-a8b3-4c41-89e4-b413f7aab89fRxCUI 1807631, 1807632, 1807633, 1807634, 1807639UNII 451W47IQ8X
- Pharmacologic class
- Osmotic Laxative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N417271070102followed by a unit qualifier and the quantityPackage 17271-0701-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207310
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-623 |
| Sodium Chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-632 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-218 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-220 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-222 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-224 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-282 |
| Sodium Chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-328 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | BECTON DICKINSON AND COMPANY | 17271-771 |
| Sodium Chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-432 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-466 |
| 0.9% Sodium Chloridesodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1577 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-474 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-468 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-470 |
| Sodium chloride | Sodium chloride 9 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-472 |